The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 18, 2017

Filed:

Jun. 05, 2014
Applicants:

Institut National DE LA Sante ET DE LA Recherche Medicale (Inserm), Paris, FR;

Universite DE Bordeaux, Bordeaux, FR;

Universite D'aix-marseille, Marseilles, FR;

Institut Jean Paoli & Irene Calmettes, Marseilles, FR;

Centre National DE LA Recherche Scientifique, Paris, FR;

Inventors:

Philippe Barthelemy, Bordeaux, FR;

Khalid Oumzil, Bordeaux, FR;

Arnaud Gissot, Bordeaux, FR;

Palma Rocchi, Marseilles, FR;

Julie Acunzo, Marseilles, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/04 (2006.01); A61K 31/70 (2006.01); A61K 31/713 (2006.01); A61K 47/48 (2006.01); C12N 15/11 (2006.01); C12N 15/113 (2010.01); A61K 45/06 (2006.01); A61K 9/127 (2006.01); A61K 31/337 (2006.01); A61K 31/712 (2006.01); A61K 31/7088 (2006.01);
U.S. Cl.
CPC ...
A61K 31/713 (2013.01); A61K 9/1271 (2013.01); A61K 31/337 (2013.01); A61K 45/06 (2013.01); A61K 47/488 (2013.01); A61K 47/48046 (2013.01); C12N 15/111 (2013.01); C12N 15/113 (2013.01); C12N 15/1135 (2013.01); A61K 31/7088 (2013.01); A61K 31/712 (2013.01); C12N 2310/11 (2013.01); C12N 2310/351 (2013.01); C12N 2310/3515 (2013.01); C12N 2330/30 (2013.01);
Abstract

The present invention concerns an oligonucleotide modified by substitution at the 3' or the 5′ end by a moiety comprising at least three saturated or unsaturated, linear or branched hydrocarbon chains comprising from 2 to 30 carbon atoms, and the use therefore as a medicament, in particular for use for treating cancer.


Find Patent Forward Citations

Loading…